Directory

>

Steven Leili

Steven Leili

Executive Director | Entrada Therapeutics

United States

View contact details (it's free)

Steven Leili

Summary

Steven Leili is a seasoned drug development professional with over 30 years of experience in toxicology, specializing in both small molecules and biologics. Currently serving as the Executive Director of Toxicology and Product Development at Entrada Therapeutics, he has a proven record of advancing drug candidates from discovery through to life-cycle management. His expertise spans various disease areas including anti-infectives and CNS, showcasing his versatility and depth of knowledge in the field. Steven has successfully led multidisciplinary project teams and has established strong relationships at the executive level, driving business growth through innovative strategies. His academic background includes a PhD in Animal Sciences and a Master's in Toxicology, underscoring his strong foundation in scientific research. In addition to his technical skills, he has a deep understanding of regulatory submissions and compliance, making him a key figure in the drug development process. He is passionate about fostering collaboration across functions to achieve common goals in pharmaceutical development.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Steven Leili

Work Experience

company logo

Executive Director at

Entrada Therapeutics

January 2023 - Present

company logo

Sr. Director, Toxicology, Product Development at

Entrada Therapeutics

June 2021 - Present

company logo

Executive Director at

Abbvie

May 2020 - April 2021

company logo

Research Fellow/Director/Executive Director at

Forest Laboratories (now Allergan)

December 2007 - May 2020

company logo

Study Director/Project Non-clinical Representative at

Bristol Myers Squibb

December 1987 - December 2007

Logos provided by Logo.dev

Steven Leili

Education

Montclair State University, Bachelor Of Science - Bs

Rutgers University, Doctor Of Philosophy - Phd

Frequently Asked Questions about Steven Leili

What is Steven Leili email address?

Steven Leili's primary email address is ******@entradatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Steven Leili work for?

Steven Leili is a Executive Director at Entrada Therapeutics, a company specializing in Commercial physical research.

Where Steven Leili graduated from?

Steven Leili holds a degree in Biology from Montclair State University.

How can I directly contact Steven Leili?

To contact Steven Leili directly, you can use the email address ******@entradatx.com. Complete contact information is available upon registration with Muraena.

Who is Steven Leili?

Steven Leili is a seasoned drug development professional with over 30 years of experience in toxicology, specializing in both small molecules and biologics. Currently serving as the Executive Director of Toxicology and Product Development at Entrada Therapeutics, he has a proven record of advancing drug candidates from discovery through to life-cycle management. His expertise spans various disease areas including anti-infectives and CNS, showcasing his versatility and depth of knowledge in the field. Steven has successfully led multidisciplinary project teams and has established strong relationships at the executive level, driving business growth through innovative strategies. His academic background includes a PhD in Animal Sciences and a Master's in Toxicology, underscoring his strong foundation in scientific research. In addition to his technical skills, he has a deep understanding of regulatory submissions and compliance, making him a key figure in the drug development process. He is passionate about fostering collaboration across functions to achieve common goals in pharmaceutical development.

Steven`s contact details

mail

******@entradatx.com

Colleagues

avatar
Andy Stadheim

Vice President

avatar
Ray Shiao

Executive Director, FP&A

avatar
Sweta Girgenrath

Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics

avatar
Kory Wentworth

Chief Financial Officer and Treasurer

avatar
Kush Parmar D

Board Member

avatar
Leo Qian

Co-Founder & Vice President, Discovery Research

avatar
Murali Mallem

Vice President | Head of CMC

avatar
Natarajan Sethuraman

President Research And Development at Entrada Therapeutics

avatar
Nathan Dowden

President and Chief Operating Officer

avatar
Katie Darius

VP, Program Governance & Portfolio Management

View Contact details (it's free)
Request Profile Removal